
1.21BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US6821431029
CUSIP
682143102
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
13.65
PEG Ratio
0.81
Book Value
-1.69
Dividend Share
-
Dividend Yield
-
Earnings Share
1.02
Wall Street Target Price
27.50
EPS Estimate Current Year
0.18
EPS Estimate Next Year
2.18
EPS Estimate Current Quarter
-0.02
EPS Estimate Next Quarter
0.065
Most Recent Quarter
-
Revenue TTM
38,422,000
Gross Profit TTM
14,732,000
EBITDA
-71,913,000
Profit Margin
324.88%
Return On Assets TTM
-18.68%
Return On Equity TTM
-576.33%
Revenue Per Share TTM
0.546
Qtly Revenue Growth YOY
14.90%
Diluted Eps TTM
1.02
Qtly Earnings Growth YOY
0.00%
Trailing PE
13.65
Forward PE
69
Price Sales TTM
26.2257
Price Book MRQ
3.8308
Enterprise Value Revenue
31
Enterprise Value EBITDA
129
536.16
0.41%965.00
0.00%136.78
0.00%195.62
-5.32%327.34
-2.89%158.00
-2.19%403.60
-2.10%33.47
-1.56%948.02
-0.91%941.25
-0.47%